Adaptive Biotechnologies Corp. (ADPT)
15.86
+0.09
(+0.57%)
USD |
NASDAQ |
Feb 09, 16:00
15.86
0.00 (0.00%)
Pre-Market: 20:00
Adaptive Biotechnologies Total Liabilities (Quarterly) : 287.74M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | -- |
| Gilead Sciences, Inc. | 37.08B |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Recursion Pharmaceuticals, Inc. | 352.58M |
| Arcellx, Inc. | 215.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 512.74M |
| Shareholders Equity (Quarterly) | 218.79M |
| Debt to Equity Ratio | 0.9614 |
| Current Ratio | 3.338 |
| Net Debt Paydown Yield | 0.11% |